Connect with us

Politics

Kentucky legalizes medical marijuana: What happens next?

Published

on


Well, here’s some positive news to cap off your week, Leafly Nation!

Earlier today, Kentucky became the 38th state to legalize medical cannabis when Governor Andy Beshear (D) signed Senate Bill 47 into law.

The victory follows failed attempts to pass similar legislation in 2020 and 2022.

While SB 47 provides a substantial overview of how the program will operate, we caution our friends in Kentucky from getting too excited: It’s gonna be a hot minute before qualifying patients can purchase medical marijuana in the Bluegrass State.

Read on to learn more about the qualifying conditions for medical cannabis in Kentucky, the types of products that the law will permit, and when shops could open their doors.

When will medical cannabis become available in Kentucky?

Medical marijuana could become available for purchase as early as January 1, 2025.

Senate Bill 47 puts the Kentucky Cabinet for Health and Family Services in charge of establishing regulations for the program. According to the bill text, that office must finalize many program policies and regulations by July 1, 2024.

 Karen O’Keefe, director of state policies at the Marijuana Policy Project said:

“Kentuckians who are suffering will finally be able to have access to safe, legal medical cannabis. We applaud the Kentucky legislature for recognizing the value of medical cannabis and passing legislation that will help provide relief and meet the needs of patients with serious medical conditions throughout the state, and are also grateful for the governor’s championing of this compassionate issue.”

What forms of medical cannabinoids can Kentucky medical patients purchase?

Kentucky’s medical marijuana patients will have access to the standard forms of marijuana—edibles, oils, tinctures, capsules, etc.—with one strange exception: 

Dispensaries cannot sell “raw” cannabis flower for smoking purposes. Buuut, patients can purchase flower to vaporize. Pre-rolls are out.

Shop highly rated dispensaries near you

Showing you dispensaries near

See all dispensaries

The bill also includes a couple of potency limits: Flower cannot contain more than 35% THC. Concentrates and topicals cannot contain more than 70% THC. Edibles cannot contain more than 10 milligrams of THC per serving. Is that bad? The flower potency and edibles potency caps should be fine, but the extracts potency cap will be problematic.

(Leafly)

“Today is an incredible victory for Kentucky,” said Matthew Bratcher, Executive Director of Kentucky NORML. “For years, Kentuckians have been calling for medical cannabis legalization and now they will have the freedom to safely access regulated, therapeutic products right here at home. While there is still work to be done, this is a historic step and we look forward to continuing our work representing Kentucky patients.”

How much cannabis can Kentucky patients possess?

Kentucky will allow medical marijuana patients to possess up to a thirty-day supply of marijuana at home, and to have up to ten days’ worth of marijuana on their person.

Officials will need to determine the quantity that constitutes a thirty-or-ten day supply.

SB 47 does not allow for homegrow. Boo.

Will Kentucky tax medical marijuana for patients?

Patients will not pay state or excise taxes on marijuana, but the state will subject dispensaries and producers to taxation.

Who will qualify as a medical cannabis patient in Kentucky?

Senate Bill 47 lays out a list of current qualifying conditions for medical marijuana. They include: 

  • Any type or form of cancer regardless of the stage
  • Chronic, severe, intractable, or debilitating pain
  • Epilepsy or any other intractable seizure disorder
  • Multiple sclerosis, muscle spasms, or spasticity
  • Chronic nausea or cyclical vomiting syndrome that has proven resistant to other conventional medical treatments
  • Post-traumatic stress disorder

Senate Bill 47 also allows for a newly-formed state office, the Kentucky Center for Cannabis, to add more qualifying conditions to the list.

The program dictates that certification only remains valid for 60 days at a time, and patients must have their initial visit in person. 

What else do potential medical patients and marijuana businesses in Kentucky need to know?

The bill contains some other important information for potential businesses and patients alike:

  • Kentucky will not allow marijuana businesses to engage in advertising.
  • A local government can decide to opt out of allowing dispensaries, but residents can vote to opt back in.
  • The state Board of Physicians and State Board of Nursing will certify practitioners to legally certify patients

Read up on legalization in your state with Leafly.



Source link

Continue Reading

cannabis control commission

$187,000 pot leadership post opens up to nationwide search

Published

on

By



The continued success of the Bay State’s legal weed business will need a “tough, strategic thinker” to oversee day-to-day administration of the agency in charge of the $7 billion pot industry, according to the Cannabis Control Commission.

The CCC has begun a nationwide job search for its second Executive Director, the person responsible for “administering and enforcing Massachusetts statutes and regulations regarding the state’s marijuana industry and reports to the five Commissioners who are appointed by the governor, state Treasurer, and Attorney General for expertise in public health, public safety, social justice, regulated industries, and corporate management/finance/securities.”

The about $187,000 per year job, according to Commissioner Bruce Stebbins, is an “exciting opportunity” for anyone willing to “plan and make difficult decisions to execute the competing priorities of an independent state agency that regulates a still-federally illegal substance.”

Read the rest of this story on BostonHerald.com.



Source link

Continue Reading

business

Marijuana rescheduling leaves regulators and sellers cautiously optimistic

Published

on

By



A move by the Biden Administration to change how marijuana is treated by federal authorities was met with cautious approval by Massachusetts state regulators, cannabis sellers, and national marijuana advocates alike.

The Drug Enforcement Agency will drop marijuana from the list of banned substances found under Schedule I of the Controlled Substances Act, where it currently sits alongside heroin and LSD. It will instead move it to Schedule III, among the likes of Tylenol with codeine and anabolic steroids. This follows the recommendation of the Department of Health and Human Services

“Rescheduling cannabis is a monumental step forward for the federal government, one that can open new avenues to research, medical use, and banking for the regulated industries states like Massachusetts have built across the country,” said Ava Callender Concepcion, the acting chair of the Bay State’s Cannabis Control Commission.

Read the rest of this story on BostonHerald.com.



Source link

Continue Reading

Cannabis

Pakistan Makes Positive Move On Cannabis

Published

on

By


Recently, Pakistan approved the passage of an ordinance that created the Cannabis Control and Regulatory Authority (CCRA). This government body is tasked to regulate the cultivation, extraction, refining, manufacturing, and sale of cannabis derivatives for medical and industrial purposes.

RELATED: How To Be Discreet When Using Weed

UN laws says if country wants to produce, process and conduct sales of cannabis-related products, it must have a federal entity to deal with supply chain and ensure international compliance.  The regulatory framework of the CCRA is the organization.

The CCRA specifies the maximum level of THC in the cannabis derivative to be 0.3 percent to avoid the abuse of medicinal products and use them recreationally.  With this move, the government plans to crack down on illicit grows in order to bring them into a licensed tax paying business.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media